Company intelligence / Profile preview

Triad Isotopes

Orlando, Florida, United Statesjdiri.com ↗

Ownership: Private
Employees: ~1000
Development stage: Commercial

Overview

Triad Isotopes operates one of the largest commercial radiopharmacy networks in the US, providing FDA-approved radiopharmaceuticals for diagnostic and therapeutic use. It serves over three million patient doses annually through more than fifty pharmacies nationwide. The company offers both SPECT and PET products including newer agents such as PSMA-targeted compounds for prostate cancer imaging. No clinical trial results are published directly by the company as it acts mainly as a distributor/manufacturer rather than an innovator.

Therapeutic areas: OncologyCardiovascularOther
Modalities: RadiopharmaceuticalSmall molecule
Industry: Contract Manufacturing Organization

Partnerships

Major group purchasing organizationsRegional health systems

Beyond the preview

Go deeper on Triad Isotopes.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Triad Isotopes.

Explore the full profile